홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
PRME
#2265
Prime Medicine, Inc. Common Stock
4.6
2
+7.94%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+7.94%
월간 변동
+6.21%
6달 변화
+35.48%
년간 변동율
+87.04%
이전 종가
4.2
8
Open
4.6
2
Bid
Ask
Low
4.6
2
High
4.6
2
양
111
마켓
주식
헬스케어
PRME
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
131.16 M
131.16 M
131.29 M
134.57 M
180.51 M
—
Valuation ratios
Enterprise value
389.62 M
200.51 M
169.4 M
278.59 M
928.63 M
1.58 B
Price to earnings ratio
-1.88
-1.77
-1.24
-1.58
-3.85
-8.44
Price to sales ratio
—
116.1
63.5
61.72
117.89
359.19
Price to cash flow ratio
-2.19
-2.82
-2.29
-3.15
-6.84
-15.09
Price to book ratio
0.54
2.26
0.36
0.58
1.48
4.68
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.16
0.14
0.16
0.19
0.13
0.62
Return on equity %
0.28
0.28
0.49
0.86
0.31
1.94
Return on invested capital %
191.8
154.15
151.97
121.05
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
25.95 K
2 025.74
3 603.3
4 787.17
4 405.96
14.82 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
25.13 K
1 936.6
3 568.78
4 716.68
4 129.14
14.35 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.5
5.58
4.78
3.56
6.61
20.52
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0.01
0
0
0
0.02
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.22
-0.14
0.37
0.32
0.22
0.78
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.47
1.61
1.1
0.79
1.33
4.82
Net current asset value per share
2.05
1.79
1.25
0.94
1.44
5.42
Tangible book value per share
1.58
1.29
0.82
0.47
1.01
3.59
Working capital per share
1.74
1.47
0.99
0.67
1.22
4.35
Book value per share
1.58
1.29
0.82
0.47
1.01
3.59
뉴스
Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates
프라임 드링크 그룹, 사모 배치 1차 마감 완료
Prime Drink Group completes first closing of private placement
Prime: Maintaining "Buy" On Solidified Catalysts For Wilson's Disease And Beyond
프라임 드링크 그룹, 최대 5백만 달러 규모의 사모 발행 발표
Prime Drink Group announces private placement to raise up to $5 million
골드만삭스, 프라임 메디슨에 ’초기 바이오’ 등급 재확인
Goldman Sachs reiterates Early-Stage Biotech rating on Prime Medicine stock
Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates
Prime Medicine appoints Matthew Hawryluk as chief business officer
NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates
Prime Medicine Momentum Amid Pipeline Progress: Why I Choose To 'Hold' For Now (PRME)